REQUEST A DEMO
Total
USD $0.00
Search more companies

Bio-Test I.P.S. S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Bio-Test I.P.S. S.A.S. Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Bio-Test I.P.S. S.A.S. is an enterprise based in Colombia. Its main office is in Soledad. It operates in the Diagnostic Imaging Centers industry. It was established on January 19, 2008. 15 (2023) employees currently work for Bio-Test I.P.S. S.A.S.. From the latest financial highlights, Bio-Test I.P.S. S.A.S. reported a net sales revenue drop of 47.66% in 2023. During that time, Bio-Test I.P.S. S.A.S.’s total assets grew by 46.18%. In 2023, Bio-Test I.P.S. S.A.S.’s net profit margin increased by 4.34%.

Headquarters
Cl 20 Cr 19 16
Soledad; Atlantico;

Contact Details: Purchase the Bio-Test I.P.S. S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Bio-Test I.P.S. S.A.S. report to view the information.
Outstanding Shares:
Purchase the Bio-Test I.P.S. S.A.S. report to view the information.
Incorporation Date:
January 19, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Company Performance
Financial values in the chart are available after Bio-Test I.P.S. S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-47.66%
Total operating revenue
-47.66%
Operating profit (EBIT)
-29.07%
EBITDA
-32.55%
Net Profit (Loss) for the Period
45.77%
Total assets
46.18%
Total equity
14.11%
Operating Profit Margin (ROS)
3.48%
Net Profit Margin
4.34%
Return on Equity (ROE)
2.67%
Debt to Equity Ratio
-23.4%
Quick Ratio
-0.27%
Cash Ratio
0.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?